Day: January 19, 2022

Growth Capital Acquisition Corp. (NASDAQ: GCAC), Cepton Technologies Partner in Upcoming Lidar SPAC Merger

Written by Customer Service on January 19, 2022. Posted in Mergers And Acquisitions.

NEW YORK, Jan. 19, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Growth Capital Acquisition Corp. (NASDAQ: GCAC) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “LiDAR Supercharges Vehicle Vision and the Transportation Transformation,” please visit: https://nnw.fm/TuFT8 It won’t be long before autonomous driving will be a standard feature on cars. The next generation of automobiles will redefine the driving experience, and investors can participate in the transportation transformation in a variety of ways, including the upcoming public listing of a leading LiDAR company, Cepton Technologies, which aims to...

Full House Resorts Announces Preliminary Fourth Quarter Results, Provides Updates on American Place and Chamonix Projects

Written by Customer Service on January 19, 2022. Posted in Earnings Releases And Operating Results.

LAS VEGAS, Jan. 19, 2022 (GLOBE NEWSWIRE) — Full House Resorts, Inc. (Nasdaq: FLL) today announced preliminary results for the fourth quarter ended December 31, 2021. The preliminary results are subject to the completion of the final financial statements and our final closing procedures. The preliminary results have not been audited or reviewed by the Company’s independent registered public accounting firm, Deloitte & Touche LLP, and should not be viewed as a substitute for full financial statements prepared in accordance with generally accepted accounting principles. The Company’s actual results may differ as a result of the Company’s financial closing procedures, final adjustments and other developments that may arise between now and the time that the Company’s results for the fourth quarter and annual period are finalized. For...

Phillips Edison & Company Issues Tax Reporting Information for 2021 Distributions

Written by Customer Service on January 19, 2022. Posted in Dividend Reports And Estimates.

CINCINNATI, Jan. 19, 2022 (GLOBE NEWSWIRE) — Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of grocery-anchored omni-channel neighborhood shopping centers, provided tax reporting information for its 2021 distributions. The tax reporting information as it will be reported on the Form 1099-DIV, on a per share basis, is as follows: Class B Common Shares; CUSIP 71844V102RecordDate PayableDate TotalDistributionper Share OrdinaryDividends TotalCapitalGainDistribution UnrecapturedSection 1250Gain (1) Return ofCapital(NontaxableDistribution) Section 199ADistributions12/31/2020 1/12/2021 0.028333 0.017779 0.005425 0.001964 0.005129 0.0177791/15/2021 2/1/2021 0.028333 0.017779 0.005425 0.001964 0.005129 0.0177792/15/2021 3/1/2021 0.028333 0.017779 0.005425 0.001964 0.005129 0.0177793/19/2021 4/1/2021 0.028333 0.017779 0.005425 0.001964 0.005129 0.0177794/19/2021 5/3/2021 0.028333 0.017779 0.005425 0.001964 0.005129 0.0177795/17/2021 6/1/2021 0.028333 0.017779 0.005425 0.001964 0.005129 0.0177796/15/2021 7/1/2021 0.028333 0.017779 0.005425 0.001964 0.005129 0.017779Class...

American Pacific Mining Defines Several Exploration Targets from Drone Magnetic Survey at its Madison Copper-Gold Project in Montana

Written by Customer Service on January 19, 2022. Posted in Public Companies.

Figure 1Madison Project MAG Survey Map and Previously Reported Sampling DataFigure 2Madison Project Surface Sampling to DateVANCOUVER, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) — American Pacific Mining Corp (CSE: USGD / OTCQB: USGDF / FWB: 1QC) (“American Pacific” or “the Company”) is pleased to report results of a recently completed Unmanned Aerial Vehicle (“UAV”) Drone magnetic survey over the Madison Property conducted in July by MWH Geo-Surveys of Reno, Nevada. A total of 344 line-kilometers (km) of UAV magnetic data was compiled at a line spacing of 25 metres (m) and 50m over an area of approximately 11.34 km². Prior to the magnetic survey, a UAV orthophoto survey was used to create a digital elevation model to guide the subsequent magnetic survey. Drone surveys are recent innovations...

CytomX Therapeutics Announces FDA Clearance of Investigational New Drug Application for CX-904 for the Treatment of Advanced Solid Tumors

Written by Customer Service on January 19, 2022. Posted in Public Companies.

– CX-904 is CytomX’s first T-cell-engaging bispecific antibody and the sixth Probody® therapeutic candidate to enter the clinic – SOUTH SAN FRANCISCO, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for CX-904, an EGFRxCD3 T-cell-engaging bispecific antibody being co-developed by CytomX and Amgen. “The impressive innovation of CX-904’s design and its advancement into the clinical setting underscores our commitment to destroying cancer differently. The CX-904 IND also marks the sixth therapeutic candidate and the third treatment modality overall to enter the clinic from our versatile and tunable...

DLH to Announce First Quarter FY22 Financial Results

Written by Customer Service on January 19, 2022. Posted in Public Companies.

ATLANTA, Jan. 19, 2022 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, will release its financial results for the fiscal first quarter ended December 31, 2021 on January 31, 2022 after the market closes. DLH will then host a conference call for the investment community at 10:00 a.m. Eastern Time on February 1, 2022 during which members of senior management will make a brief presentation focused on the financial results and operating trends. A question-and-answer session will follow. Interested parties may listen to the conference call by dialing 888-347-5290 or 412-317-5256. Presentation materials will also be posted on the Investor Relations section of the DLH website prior to the commencement of the conference call. A digital...

M Health Fairview University of Minnesota Medical Center Receives First Hyperfine Portable MRI to Grow its Advanced Imaging Systems Offering

Written by Customer Service on January 19, 2022. Posted in Public Companies.

World’s first FDA-cleared portable MRI expands leading neurosurgery suite’s tech capabilities for novel diagnostic and therapeutic approaches GUILFORD, Conn. and MINNEAPOLIS, Jan. 19, 2022 (GLOBE NEWSWIRE) — Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine”), creator of the first U.S. Food and Drug Administration (“FDA”) cleared portable magnetic resonance imaging (“MRI”)™ device, Swoop®, is proud to announce that M Health Fairview is deploying a Swoop system in the emergency room (ER), intensive care unit (ICU) and post anesthesia environments at M Health Fairview University of Minnesota Medical Center. The hospital is the first in the state of Minnesota, and one of the first in the country, to offer this technology to its patients. “Forward thinking academic institutions like University of Minnesota are leading the charge adopting...

SmileDirectClub Expands Oral Care Line With Launch Of Innovative New Fast-Dissolving Whitening Strips

Written by Customer Service on January 19, 2022. Posted in Public Companies.

Leading Oral Care Company Has Teamed with Peloton Star Tunde Oyeneyin to Promote the Power of a Bright and Healthy SmileSmileDirectClubFast-Dissolving Whitening StripsSmileDirectClubTunde OyeneyinNASHVILLE, Tenn., Jan. 19, 2022 (GLOBE NEWSWIRE) — SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced the expansion of its award-winning whitening product line with its new Fast-Dissolving Whitening Strips. The new convenient and easy to use Fast-Dissolving Whitening Strips are the ideal whitening treatment for those who want results fast, without the mess of traditional whitening strips. With a short wear time – just once a day for 15 minutes – the Fast-Dissolving Whitening Strips are perfect for those who...

Qorvo® to Webcast Quarterly Earnings Conference Call on February 2, 2022

Written by Customer Service on January 19, 2022. Posted in Public Companies.

GREENSBORO, N.C., Jan. 19, 2022 (GLOBE NEWSWIRE) — Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, will host a conference call to review fiscal 2022 third quarter financial results on Wednesday, February 2, 2022, at 5:00 p.m. (ET). The conference call will be webcast live on the Company’s website at the following URL: http://www.qorvo.com (under “Investors”). A telephone playback of the conference call will be available approximately two hours after the call’s completion and can be accessed by dialing 719-457-0820 and using the passcode 5371000. The playback will be available through the close of business February 9, 2022. Qorvo will distribute fiscal 2022 third quarter financial results at approximately 4:00 p.m. (ET) on Wednesday, February 2, 2022. About QorvoQorvo (Nasdaq: QRVO)...

Recce Pharmaceuticals Announces Positive Safety Data from Second Cohort of Phase I Clinical Trial Evaluating Healthy Subjects Intravenously Dosed with RECCE® 327

Written by Customer Service on January 19, 2022. Posted in Public Companies.

Highlights:Seven subjects in cohort two intravenously dosed with RECCE® 327 (R327) at 150mg met all endpoints – indicating R327 is safe and well tolerated Independent Safety Committee clears third study cohort to be dosed at 500mg – a tenfold increase from cohort one (50mg) and a threefold increase from cohort two (150mg) in dose per approved protocol Third cohort dosing of R327 (500mg) on track to begin this weekSYDNEY, Australia, Jan. 19, 2022 (GLOBE NEWSWIRE) — Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the company developing new classes of synthetic anti-infectives, is pleased to report further positive data from its Phase I intravenous (IV) clinical trial of RECCE® 327 (R327), demonstrating safety and tolerability among seven healthy male subjects in cohort two. Based upon these clinical data...

Day: January 19, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice